Literature DB >> 20412055

MicroRNAs and the regulation of fibrosis.

Xiaoying Jiang1, Eleni Tsitsiou, Sarah E Herrick, Mark A Lindsay.   

Abstract

MicroRNAs (miRNAs) are small, noncoding RNAs of 18-25 nucleotides that are generally believed to either block the translation or induce the degradation of target mRNA. miRNAs have been shown to play fundamental roles in diverse biological and pathological processes, including cell proliferation, differentiation, apoptosis and carcinogenesis. Fibrosis results from an imbalance in the turnover of extracellular matrix molecules and is a highly debilitating process that can eventually lead to organ dysfunction. A growing body of evidence suggests that miRNAs participate in the fibrotic process in a number of organs including the heart, kidney, liver and lung. In this review, we summarize our current understanding of the role of miRNAs in the development of tissue fibrosis and their potential as novel drug targets.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20412055      PMCID: PMC2963651          DOI: 10.1111/j.1742-4658.2010.07632.x

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  45 in total

1.  The widespread impact of mammalian MicroRNAs on mRNA repression and evolution.

Authors:  Kyle Kai-How Farh; Andrew Grimson; Calvin Jan; Benjamin P Lewis; Wendy K Johnston; Lee P Lim; Christopher B Burge; David P Bartel
Journal:  Science       Date:  2005-11-24       Impact factor: 47.728

Review 2.  Post-transcriptional gene silencing by siRNAs and miRNAs.

Authors:  Witold Filipowicz; Lukasz Jaskiewicz; Fabrice A Kolb; Ramesh S Pillai
Journal:  Curr Opin Struct Biol       Date:  2005-06       Impact factor: 6.809

3.  Nicotine, atrial fibrosis, and atrial fibrillation: do microRNAs help to clear the smoke?

Authors:  Andreas Goette
Journal:  Cardiovasc Res       Date:  2009-06-05       Impact factor: 10.787

4.  Changes in microRNAs associated with hepatic stellate cell activation status identify signaling pathways.

Authors:  Can-Jie Guo; Qin Pan; Tao Cheng; Bo Jiang; Guang-Yu Chen; Ding-Guo Li
Journal:  FEBS J       Date:  2009-08-10       Impact factor: 5.542

Review 5.  Cardiac fibroblast: the renaissance cell.

Authors:  Colby A Souders; Stephanie L K Bowers; Troy A Baudino
Journal:  Circ Res       Date:  2009-12-04       Impact factor: 17.367

6.  Effects of upregulated expression of microRNA-16 on biological properties of culture-activated hepatic stellate cells.

Authors:  Can-Jie Guo; Qin Pan; Bo Jiang; Guang-Yu Chen; Ding-Guo Li
Journal:  Apoptosis       Date:  2009-11       Impact factor: 4.677

7.  MicroRNA expression profile in Lieber-DeCarli diet-induced alcoholic and methionine choline deficient diet-induced nonalcoholic steatohepatitis models in mice.

Authors:  Angela Dolganiuc; Jan Petrasek; Karen Kodys; Donna Catalano; Pranoti Mandrekar; Arumugam Velayudham; Gyongyi Szabo
Journal:  Alcohol Clin Exp Res       Date:  2009-07-01       Impact factor: 3.455

Review 8.  Strategies for treating idiopathic pulmonary fibrosis.

Authors:  R M du Bois
Journal:  Nat Rev Drug Discov       Date:  2010-01-22       Impact factor: 84.694

9.  Downregulation of miR-133 and miR-590 contributes to nicotine-induced atrial remodelling in canines.

Authors:  Hongli Shan; Yong Zhang; Yanjie Lu; Ying Zhang; Zhenwei Pan; Benzhi Cai; Ning Wang; Xuelian Li; Tieming Feng; Yuan Hong; Baofeng Yang
Journal:  Cardiovasc Res       Date:  2009-04-27       Impact factor: 10.787

10.  Identification of keratinocyte growth factor as a target of microRNA-155 in lung fibroblasts: implication in epithelial-mesenchymal interactions.

Authors:  Nicolas Pottier; Thomas Maurin; Benoit Chevalier; Marie-Pierre Puisségur; Kevin Lebrigand; Karine Robbe-Sermesant; Thomas Bertero; Christian L Lino Cardenas; Elisabeth Courcot; Géraldine Rios; Sandra Fourre; Jean-Marc Lo-Guidice; Brice Marcet; Bruno Cardinaud; Pascal Barbry; Bernard Mari
Journal:  PLoS One       Date:  2009-08-24       Impact factor: 3.240

View more
  114 in total

1.  Roles of microRNA-29a in the antifibrotic effect of farnesoid X receptor in hepatic stellate cells.

Authors:  Jiang Li; Yifei Zhang; Ramalinga Kuruba; Xiang Gao; Chandrashekhar R Gandhi; Wen Xie; Song Li
Journal:  Mol Pharmacol       Date:  2011-04-21       Impact factor: 4.436

2.  Farnesoid X receptor protects hepatocytes from injury by repressing miR-199a-3p, which increases levels of LKB1.

Authors:  Chan Gyu Lee; Young Woo Kim; Eun Hyun Kim; Zhipeng Meng; Wendong Huang; Se Jin Hwang; Sang Geon Kim
Journal:  Gastroenterology       Date:  2012-01-18       Impact factor: 22.682

Review 3.  MicroRNAs in liver disease.

Authors:  Xin Wei Wang; Niels H H Heegaard; Henrik Orum
Journal:  Gastroenterology       Date:  2012-04-11       Impact factor: 22.682

4.  MicroRNA expression abnormalities in limited cutaneous scleroderma and diffuse cutaneous scleroderma.

Authors:  Honglin Zhu; Yisha Li; Shunlin Qu; Hui Luo; Yaou Zhou; Yanping Wang; Hongjun Zhao; Yunhui You; Xianzhong Xiao; Xiaoxia Zuo
Journal:  J Clin Immunol       Date:  2012-02-04       Impact factor: 8.317

Review 5.  The role of microRNAs in skin fibrosis.

Authors:  Olubukola Babalola; Andrew Mamalis; Hadar Lev-Tov; Jared Jagdeo
Journal:  Arch Dermatol Res       Date:  2013-11       Impact factor: 3.017

6.  Implication of the miR-184 and miR-204 competitive RNA network in control of mouse secondary cataract.

Authors:  Andrea Hoffmann; Yusen Huang; Rinako Suetsugu-Maki; Carol S Ringelberg; Craig R Tomlinson; Katia Del Rio-Tsonis; Panagiotis A Tsonis
Journal:  Mol Med       Date:  2012-05-09       Impact factor: 6.354

7.  MicroRNA-21 in scleroderma fibrosis and its function in TGF-β-regulated fibrosis-related genes expression.

Authors:  Honglin Zhu; Hui Luo; Yisha Li; Yaou Zhou; Ying Jiang; Jin Chai; Xianzhong Xiao; Yunhui You; Xiaoxia Zuo
Journal:  J Clin Immunol       Date:  2013-05-09       Impact factor: 8.317

Review 8.  microRNAs: fad or future of liver disease.

Authors:  Ashley M Lakner; Herbert L Bonkovsky; Laura W Schrum
Journal:  World J Gastroenterol       Date:  2011-05-28       Impact factor: 5.742

Review 9.  Modulation of immune responses following solid organ transplantation by microRNA.

Authors:  Nayan J Sarma; Venkataswarup Tiriveedhi; Sabarinathan Ramachandran; Jeffrey Crippin; William Chapman; T Mohanakumar
Journal:  Exp Mol Pathol       Date:  2012-10-01       Impact factor: 3.362

10.  MiR-3606-3p inhibits systemic sclerosis through targeting TGF-β type II receptor.

Authors:  Xiangguang Shi; Qingmei Liu; Na Li; Wenzhen Tu; Ruoyu Luo; Xueqian Mei; Yanyun Ma; Weihong Xu; Haiyan Chu; Shuai Jiang; Zhimin Du; Han Zhao; Liang Zhao; Li Jin; Wenyu Wu; Jiucun Wang
Journal:  Cell Cycle       Date:  2018-09-17       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.